Project Number 2R44AG061995-02A1 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Preclinical Characterization of CRAC Channel Inhibitors for the Treatment of Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) f. Inflammation Researcher and Organization Principal Investigator GREENBERG, MILTON L Principal Investigator First Name MILTON Principal Investigator Last Name GREENBERG Awardee Organization VIVREON BIOSCIENCES, LLC Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $1,276,596 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
